Correlates of health-related quality of life in French people with type 2 diabetes

https://doi.org/10.1016/j.diabres.2013.05.011Get rights and content

Abstract

Aim

Diabetes is known to impair health-related quality of life (HrQol). Our aim was to analyse a comprehensive set of potential determinants of HrQol in a large sample of patients with diabetes.

Methods

This study is based on the ENTRED 2007 study, a representative sample of adults (18 years and older) with diabetes. Data were extracted from postal self-reported questionnaires (from patients and medical practitioners) and from reimbursements from the National health insurance data system. HrQol was assessed with the MOS SF-12 for mental (MCS) and physical (PCS) component summaries. Multivariate linear regression models were used to analyse the variables associated with HrQol.

Results

SF-12 MCS and PCS were available in 2832 patients with T2DM, with a mean age 64 years (1715 males, 56%). Lower income, severe hypoglycaemic episodes, hospitalisation ≥24 h, instrumental daily living (IADL) restriction, low satisfaction for social support and an HbA1c within the 8.1–10.0% range were associated with lower MCS rating, whereas an older age and male gender were associated with higher MCS. Older age, female sex, higher BMI, lower income, insulin treatment, macrovascular complications, severe hypoglycaemic episodes, hospitalisation ≥24 h, and IADL restriction were associated with lower PCS values whereas having no need for social support was associated with higher PCS values.

Discussion

HrQol associated factors are multiple but mainly linked with socio-demographic factors, diabetes complications and satisfaction for social support. A patient centred approach should be tested to prevent impairment of HrQol and thus to decrease the burden of diabetes. Assessment of social support should be included.

Introduction

Type 2 diabetes (T2D) is one of the most frequent chronic diseases in adults reaching 3.2% in French people older than 18 years and 11% in those older than 65 years [1]. The burden of diabetes is known to be heavy, as it involves high rates of disability, participation restrictions and decreased life expectancy. The health burden of diabetes is associated with an increasing economic burden, particularly in the oldest [2]. Effective interventions are thus needed to decrease these negative impacts in various populations with diabetes.

Patient's perception of his/her own quality of life is considered as a valuable basis to identify targets for improvement. Health-related quality of life (HrQoL) is therefore one of the major end-points of recent clinical trials in people with diabetes [3], [4]. HrQoL assessment with the generic instrument SF-36 or its shorter version SF-12 has been used in people in T2D along with diabetes-specific instruments. The SF12 questionnaire is an instrument used to measure overall physical and mental health. Using a generic instrument allows comparisons with the general population. In France, in 2003, a previous large cross-sectional study obtained SF-36 scores in 22,743 community dwellers aged 18–84 years old including 3.4% patients with diabetes [5]. Diabetes was shown to be a predictor of lower scores in all of the 8 subscales independently of socio-economic status and diseases such as ischaemic heart disease, heart failure, cancer and hypertension. Similar results have been shown in German [6] or Korean populations [7]. However, in people with T2D and with diverse co-morbidities, the impact of diabetes on HrQoL is not easily distinguishable from that of other diseases or disabilities [8], [9]. Previous studies investigating HrQoL in populations with T2D may have been of limited power due to limited sample sizes [10], [11], [12], [13], or may have addressed only specific populations [14], [15], [16]. In a study focused on 7606 people with chronic diseases, including 14% people with diabetes, factors associated with lower HrQoL scores were not limited to the disease and its consequences but depended strongly on socio-economic factors [17]. Thus, although it has been shown that HrQol was associated with the characteristics of the diabetes disease [18], estimating the respective contribution of diverse factors on HrQol is necessary to better evaluate any intervention. For this purpose, a high power study is needed to assess the relative influences of multiple factors on HrQol.

Using the large ENTRED 2007 cross-sectional study (Échantillon national témoin représentatif des personnes diabétiques), based on a representative of adults with diabetes living in metropolitan France in 2007 [19], the aim of our analysis was to assess HrQol in people with T2D and to estimate the relative contributions of socio-demographic factors, diabetes characteristics, complications and treatment, social support and functional impairment in daily living, in mental and physical components of HrQol.

Section snippets

Population

The ENTRED 2007 study is based on a representative sample of 8926 adults with diabetes, aged 18 years and over, treated for diabetes and living in metropolitan France. This sample was randomly extracted from the database of two National Health Insurance Services: The health insurance for employers and their relatives, CNAMTS (Caisse Nationale d’Assurance Maladie, 75% of people living in France) and the health insurance of independent workers (RSI, 5% of people living in France) from all

Results

PQ were available in 48% of the sample (among those with type 2 diabetes: n = 3894 or 2282 males, 1612 females). MQ were obtained for 57% of the responders with type 2 diabetes (N = 2232). SF-12 MCS and PCS were available in 2832 patients with T2D (Fig. 1). Missing responses in the PQ led to missing SF-12 summaries in 1062 patients. Non respondents to PQ and those with missing SF12 were older than the respondents (65.4 years (SD 14.3) vs. 63.8 years (SD 10.8), p < 0.0001), and more often women (48.1%

Discussion

The factors associated with lower scores of HrQol summaries in French patients with type 2 diabetes are multiple, in relation with socio-economic conditions, social support, diabetes complications, disability and social participation restriction. The effect of current blood poor glucose control is somewhat weak and seen only for mental and not physical HrQol, and diabetes duration had no impact on HrQol after adjustment.

According to age and sex, trends for SF-12 summaries in ENTRED are similar

Scientific committee ENTRED

C. Attali, C. Avril, M. Besnier, J. Bloch, I. Bourdel-Marchasson, M. Chantry, B. Detournay, E. Eschwège, A. Fagot-Campagna, S. Fosse, A. Fontbonne, C. Fournier, A. Gautier, S. Halimi, P. Lecomte, A. Paumier, A. Penfornis, N. Poutignat, I. Romon, C. Roudier, A. Rudnichi, D. Simon, M. Varroud-Vidal, P. Vexiau, A. Weill.

Funding

The analysis of HrQol in the ENTRED study has been funded by French Institute of Health Monitoring, (Institut de veille sanitaire, InVS).

Conflict of interest

The authors declare that they have no conflict of interest.

Author contribution

I. Bourdel-Marchasson has participated in the ENTRED study questionnaire construction, has planned the HrQoL analysis and has written the paper. C. Druet is the head of the diabetes department of InVs and has contributed to the interpretation of data and to the writing of the paper. C. Helmer has monitored the statistical analysis and has contributed to the interpretation of data and to the writing of the paper. E. Eschwege, P. Lecomte and A.J. Sinclair have contributed to the interpretation of

Acknowledgements

Fundings of Entred 2007 study came from the French Institute of Health Monitoring, (Institut de veille sanitaire, InVS), The French National Health Insurance service (Caisse Nationale de l’Assurance Maladie CnamTS), the Health Insurance System for independent workers (Régime des Salariés Indépendants, RSI), the French National Institut for Prevention and Health Education (Institut national de prévention et d’éducation pour la santé, Inpes), and the French Health Authority (Haute Autorité de

References (44)

  • I. Bourdel Marchasson

    Models of care, the European perspective

  • D. Ose et al.

    Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity

    Diabetes Care

    (2009)
  • J. Speight et al.

    Not all roads lead to Rome – a review of quality of life measurement in adults with diabetes

    Diabet Med

    (2009)
  • E. Audureau et al.

    Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995–2003

    Qual Life Res

    (2012)
  • M. Schunk et al.

    Health-related quality of life in subjects with and without type 2 diabetes: pooled analysis of five population-based surveys in Germany

    Diabet Med

    (2012)
  • Y.J. Choi et al.

    The relationship between diabetes mellitus and health-related quality of life in Korean adults: the Fourth Korea National Health and Nutrition Examination Survey (2007–2009)

    Diabetes Metab J

    (2011)
  • A.J. Woodcock et al.

    Problems with the performance of the SF-36 among people with type 2 diabetes in general practice

    Qual Life Res

    (2001)
  • A. Miksch et al.

    Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany – a cross-sectional survey

    Health Qual Life Outcomes

    (2009)
  • A.H. Al-Shehri et al.

    Health-related quality of life in type 2 diabetic patients

    Ann Saudi Med

    (2008)
  • J.A. Johnson et al.

    Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes

    Qual Life Res

    (2004)
  • M. Sundaram et al.

    Quality of life, health status and clinical outcomes in type 2 diabetes patients

    Qual Life Res

    (2007)
  • M. Kamarul Imran et al.

    Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36

    Singapore Med J

    (2010)
  • Cited by (38)

    • Evaluation of the quality of life of patients with diabetes mellitus treated with conventional or analogue insulins

      2016, Diabetes Research and Clinical Practice
      Citation Excerpt :

      Despite this finding, the studies mentioned above were sponsored by the pharmaceutical industry, and their authors declared conflicts of interest, which may challenge the results. A study conducted in France used the Medical Outcomes Study Short Form Health Survey 12 (MOS SF-12) instrument and showed that some of the variables associated with poor quality of life in patients with diabetes mellitus included low income, low educational level, long-term evolution of the disease, history of severe hypoglycaemia and insulin treatment [20], which it is similar to the findings of the present study and to those reported by Davis et al. in 2001 [37]. Also, the increased risk for poor quality of life found in patients older than 60 years, as was found in the study of Hervas can be due to the sum of various factors, including a higher incidence of comorbidities and polypharmacy, long-term illness, secondary complications of diabetes, lower education, poor social support [24], and even, as described in the ADVANCE study may be part of the ageing process [38].

    View all citing articles on Scopus
    View full text